Literature DB >> 22905990

Assessment of individual susceptibility to baseline DNA and cytogenetic damage in a healthy Turkish population: evaluation with lifestyle factors.

Ela Kadioglu1, Neslihan Aygun Kocabas, Gonca Cakmak Demircigil, Erdem Coskun, Eren Ozcagli, Emre Durmaz, Bensu Karahalil, Sema Burgaz, Semra Sardas.   

Abstract

BACKGROUND: Cytogenetic biomarkers are most frequently used well-established endpoints in human population studies with their sensitivity for measuring exposure to genotoxic agents. They have an important role as early predictors of cancer risk. Identification of individual genotypes of metabolic gene polymorphisms helps to understand the modulation of cancer susceptibility by environmental exposures, such as cigarette smoking and other lifestyle factors. AIM: To evaluate individual susceptibility to chemicals, we determined individual DNA damage related to glutathione S-transferase (GST) genotypes (GSTM1, GSTT1, and GSTP1) in a Turkish population.
METHODS: Peripheral blood lymphocytes (PBL) and DNA samples of 127 subjects were analyzed for the presence of DNA damage, using single-cell gel electrophoresis (the Comet assay), and for cytogenetic parameters (chromosomal aberrations [CAs], bleomycin-induced CA, and a cytokinesis-blocked micronucleus assay), and the polymerase chain reaction/restriction fragment length polymorphism method, respectively.
RESULTS: Individuals carrying a GSTT1-null allele showed higher frequencies of CA and micronucleus (MN) (p=0.026, p=0.003, respectively), whereas the GSTM1-null and GSTP1 mutant genotypes did not show any differences in cytogenetic parameters. Our findings demonstrated that none of the lifestyle factors (smoking, alcohol drinking, dietary habits, vitamin intake, and physical activity), except for vitamin intake (p=0.002), were significantly associated with the studied cytogenetic parameters.
CONCLUSION: Our results suggest that the GSTT1 gene polymorphism may influence the baseline cytogenetic frequency in a healthy population.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22905990      PMCID: PMC3468102          DOI: 10.1089/gtmb.2012.0038

Source DB:  PubMed          Journal:  Genet Test Mol Biomarkers        ISSN: 1945-0257


  46 in total

1.  Sister chromatid exchange and micronucleus frequency in human lymphocytes of 1,650 subjects in an Italian population: II. Contribution of sex, age, and lifestyle.

Authors:  R Barale; L Chelotti; T Davini; S Del Ry; M G Andreassi; M Ballardin; M Bulleri; J He; S Baldacci; F Di Pede; F Gemignani; S Landi
Journal:  Environ Mol Mutagen       Date:  1998       Impact factor: 3.216

2.  Biological monitoring of young workers exposed to polycyclic aromatic hydrocarbons in engine repair workshops.

Authors:  B Karahalil; S Burgaz; G Fişek; A E Karakaya
Journal:  Mutat Res       Date:  1998-02-13       Impact factor: 2.433

3.  Polymorphism in glutathione S-transferase P1 is associated with susceptibility to chemotherapy-induced leukemia.

Authors:  J M Allan; C P Wild; S Rollinson; E V Willett; A V Moorman; G J Dovey; P L Roddam; E Roman; R A Cartwright; G J Morgan
Journal:  Proc Natl Acad Sci U S A       Date:  2001-09-11       Impact factor: 11.205

Review 4.  Genetic polymorphisms and chromosome damage.

Authors:  H Norppa
Journal:  Int J Hyg Environ Health       Date:  2001-10       Impact factor: 5.840

5.  Influence of GSTM1 genotype on comet assay and chromosome aberrations after induction by bleomycin in cultured human lymphocytes.

Authors:  N A Kocabaş; B Karahalil; A E Karakaya; S Sardaş
Journal:  Mutat Res       Date:  2000-09-20       Impact factor: 2.433

Review 6.  The in vitro micronucleus technique.

Authors:  M Fenech
Journal:  Mutat Res       Date:  2000-11-20       Impact factor: 2.433

Review 7.  Biological indicators of genotoxic risk and metabolic polymorphisms.

Authors:  S Pavanello; E Clonfero
Journal:  Mutat Res       Date:  2000-10       Impact factor: 2.433

8.  Assessment of DNA strand breakage by comet assay in diabetic patients and the role of antioxidant supplementation.

Authors:  S Sardaş; M Yilmaz; U Oztok; N Cakir; A E Karakaya
Journal:  Mutat Res       Date:  2001-02-20       Impact factor: 2.433

9.  HUman MicroNucleus project: international database comparison for results with the cytokinesis-block micronucleus assay in human lymphocytes: I. Effect of laboratory protocol, scoring criteria, and host factors on the frequency of micronuclei.

Authors:  S Bonassi; M Fenech; C Lando; Y P Lin ; M Ceppi; W P Chang; N Holland; M Kirsch-Volders; E Zeiger; S Ban; R Barale; M P Bigatti; C Bolognesi; C Jia; M Di Giorgio; L R Ferguson; A Fucic; O G Lima; P Hrelia; A P Krishnaja; T K Lee; L Migliore; L Mikhalevich; E Mirkova; P Mosesso; W U Müller; Y Odagiri; M R Scarffi; E Szabova; I Vorobtsova; A Vral; A Zijno
Journal:  Environ Mol Mutagen       Date:  2001       Impact factor: 3.216

10.  Carcinomas of the renal pelvis associated with smoking and phenacetin abuse: p53 mutations and polymorphism of carcinogen-metabolising enzymes.

Authors:  P P Bringuier; M McCredie; G Sauter; M Bilous; J Stewart; M J Mihatsch; P Kleihues; H Ohgaki
Journal:  Int J Cancer       Date:  1998-10-23       Impact factor: 7.396

View more
  3 in total

1.  Polymorphisms of GSTM1, GSTT1, GSTP1 genes and chromosomal aberrations in lung cancer patients.

Authors:  Varvara I Minina; Olga A Soboleva; Andrey N Glushkov; Elena N Voronina; Ekaterina A Sokolova; Marina L Bakanova; Yana A Savchenko; Anastasia V Ryzhkova; Ruslan A Titov; Vladimir G Druzhinin; Maxim Yu Sinitsky; Maxim A Asanov
Journal:  J Cancer Res Clin Oncol       Date:  2017-08-02       Impact factor: 4.553

Review 2.  Genotoxicity of Anesthetics Evaluated In Vivo (Animals).

Authors:  Mariana G Braz; Bensu Karahalil
Journal:  Biomed Res Int       Date:  2015-06-24       Impact factor: 3.411

3.  The role of oxidative DNA damage and GSTM1, GSTT1, and hOGG1 gene polymorphisms in coronary artery disease risk.

Authors:  Ela Kadıoğlu; Gülten Taçoy; Eren Özçağlı; Kaan Okyay; Mehmet K Akboğa; Atiye Çengel; Semra Şardaş
Journal:  Anatol J Cardiol       Date:  2016-04-26       Impact factor: 1.596

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.